Matthias Preusser

Medical University

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Cancer Biology Cancer Biology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Ahmed Idbaih

Sorbonne Université

FRANCE

View details

Cihan Ay

Professor, MD

Medical University of Vienna

AUSTRIA

View details

Martin van den Bent

Erasmus University Rotterdam

NETHERLANDS

View details

Hannah Christina Puhr

Medical University of Vienna

AUSTRIA

View details

Ghazaleh Tabatabai

Professor

Eberhard Karls Universität Tübingen

GERMANY

View details

Craig Horbinski

Northwestern University

UNITED STATES

View details

Jan-Michael Werner

University of Cologne

GERMANY

View details

Karin Piil

Copenhagen University Hospital

DENMARK

View details

Tony J.C. Wang

UNITED STATES

View details

Stephan Nopp

Medical University of Vienna

AUSTRIA

View details

Cornelia Englisch

Medical University of Vienna

AUSTRIA

View details

Valerie Treyer

SWITZERLAND

View details

Simon Kraler

SWITZERLAND

View details

Wolfgang Wick

University Hospital Heidelberg

GERMANY

View details

Ellen Gelpi

AUSTRIA

View details

Luzia Berchtold

Medical University of Vienna

AUSTRIA

View details

Michael Platten

Heidelberg University

GERMANY

View details

Arnold von Eckardstein

chairman of the institute/ professor

University of Zurich

SWITZERLAND

View details

Florien Boele

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthias Preusser

Research Interests

Explore related searches

Contact this professor

Articles (29)

Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas

Validation of risk assessment models for venous thromboembolism in patients with cancer receiving systemic therapies

Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?

Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Update to the RANO Working Group and EANO recommendations for the clinical use of PET imaging in gliomas

Response to letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022

Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?

Point/Counterpoint: The role of reirradiation in recurrent glioblastoma

Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?

Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals’ perspectives

Targeted radionuclide therapy for gliomas: emerging clinical trial landscape

Chairing scientific sessions at international Neuro-Oncology meetings: An EANO guide for early-career professionals

European Association of Neuro-Oncology’s 30th anniversary: A successful and growing relationship with Neuro-Oncology Practice

NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases

Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study

IDH inhibition in gliomas: from preclinical models to clinical trials

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0

Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study

Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study

Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101

What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?

Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana?

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy

Enhanced expression of autophagy‐related p62 without increased deposits of neurodegeneration‐associated proteins in glioblastoma and surrounding tissue – An autopsy‐based study

Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma

Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma

Enhanced expression of autophagy-related p62 without increased deposits of neurodegeneration-associated proteins in glioblastoma and surrounding tissue - An autopsy-based study

Collaborators (19)

Ahmed Idbaih

Cihan Ay

Martin van den Bent

Hannah Christina Puhr

Ghazaleh Tabatabai

Craig Horbinski

Jan-Michael Werner

Karin Piil

Tony J.C. Wang

Stephan Nopp

Cornelia Englisch

Valerie Treyer

Simon Kraler

Wolfgang Wick

Ellen Gelpi

Luzia Berchtold

Michael Platten

Arnold von Eckardstein

Florien Boele

Make your next move.